HIGHLIGHTS
- who: Kullasate Sakpichaisakul from the (UNIVERSITY) have published the research: Epileptic spasms related to neuronal differentiation factor 2 (NEUROD2) mutation respond to combined vigabatrin and high dose prednisolone therapy, in the Journal: (JOURNAL)
- what: The authors propose that related to de novo pathogenic variant respond well to combined and high-dose therapy. The authors provide the electroclinical characteristics of epileptic spasms with multiple relapses responding to combining vigabatrin and high-dose prednisolone therapy in a patient with NEURODrelated NDD syndrome.
SUMMARY
Variants on electroencephalography (EEG) and developmental delay. Treatment options are . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.